GENERAL ATLANTIC, L.P. Diversified Active

Location: New York, NY

CIK: 0001017645 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $3.18B (100.0% shares, 0.0% debt)

Holdings (19)

XP XP, INC 16.4%

Value $521M Shares 29,617,733 Est. Cost — Unrealized —

DLO DLOCAL 16.3%

Value $517M Shares 63,906,695 Est. Cost — Unrealized —

ALKT ALKAMI 15.4%

Value $489M Shares 17,186,985 Est. Cost — Unrealized —

ALHC ALIGNMENT HEALTHCARE 15.0%

Value $477M Shares 60,993,323 Est. Cost — Unrealized —

— SQUARESPACE 14.6%

Value $463M Shares 10,611,073 Est. Cost — Unrealized —

PHVS PHARVARIS 4.5%

Value $142M Shares 7,531,252 Est. Cost — Unrealized —

EWCZ EUROPEAN WAX CENTER 4.1%

Value $130M Shares 13,110,492 Est. Cost — Unrealized —

— AKERO THERAPEUTICS 3.9%

Value $123M Shares 5,233,989 Est. Cost — Unrealized —

CNTA CENTESSA PHARMACEUTICALS 2.7%

Value $87.43M Shares 9,681,818 Est. Cost — Unrealized —

BLND BLEND LABS 1.4%

Value $45.15M Shares 19,132,440 Est. Cost — Unrealized —

IMCR IMMUNOCORE 1.3%

Value $42.76M Shares 1,261,684 Est. Cost — Unrealized —

RPRX ROYALTY PHARMA 1.2%

Value $39.55M Shares 1,500,000 Est. Cost — Unrealized —

— THIRD HARMONIC BIO 1.2%

Value $38.46M Shares 2,958,762 Est. Cost — Unrealized —

RSKD RISKIFIED 1.1%

Value $34.03M Shares 5,324,998 Est. Cost — Unrealized —

— ACELYRIN 0.4%

Value $12.74M Shares 2,889,668 Est. Cost — Unrealized —

OPEN OPENDOOR 0.4%

Value $11.63M Shares 6,321,519 Est. Cost — Unrealized —

Value $3.481M Shares 609,616 Est. Cost — Unrealized —

GROV GROVE COLLABORATIVE 0.1%

Value $1.657M Shares 936,020 Est. Cost — Unrealized —

ADAG ADAGENE 0.0%

Value $808K Shares 264,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
XP	XP, INC	29,617,733	$521M	16.4%	—	—	CL A	G98239109
DLO	DLOCAL	63,906,695	$517M	16.3%	—	—	CL A	G29018101
ALKT	ALKAMI	17,186,985	$489M	15.4%	—	—	COM	01644J108
ALHC	ALIGNMENT HEALTHCARE	60,993,323	$477M	15.0%	—	—	COM	01625V104
—	SQUARESPACE	10,611,073	$463M	14.6%	—	—	CL A	85225A107
PHVS	PHARVARIS	7,531,252	$142M	4.5%	—	—	COM	N69605108
EWCZ	EUROPEAN WAX CENTER	13,110,492	$130M	4.1%	—	—	CL A	29882P106
—	AKERO THERAPEUTICS	5,233,989	$123M	3.9%	—	—	COM	00973Y108
CNTA	CENTESSA PHARMACEUTICALS	9,681,818	$87.43M	2.7%	—	—	ADS	152309100
BLND	BLEND LABS	19,132,440	$45.15M	1.4%	—	—	CL A	09352U108
IMCR	IMMUNOCORE	1,261,684	$42.76M	1.3%	—	—	ADS	45258D105
RPRX	ROYALTY PHARMA	1,500,000	$39.55M	1.2%	—	—	CL A	G7709Q104
—	THIRD HARMONIC BIO	2,958,762	$38.46M	1.2%	—	—	COM	88427A107
RSKD	RISKIFIED	5,324,998	$34.03M	1.1%	—	—	SHS CL A	M8216R109
—	ACELYRIN	2,889,668	$12.74M	0.4%	—	—	COM	00445A100
OPEN	OPENDOOR	6,321,519	$11.63M	0.4%	—	—	COM	683712103
—	WISH	609,616	$3.481M	0.1%	—	—	CL A	21077C305
GROV	GROVE COLLABORATIVE	936,020	$1.657M	0.1%	—	—	CL A	39957D201
ADAG	ADAGENE	264,000	$808K	0.0%	—	—	ADS	005329107